I agree that Leo will package the results of B-OM
Post# of 72447
Notice the word "partnerships" is plural.

"With a number of upcoming anticipated clinical milestones (see below), management is hopeful that partnerships can be struck in 2017 to help advance Cellceutix's pipeline of First-in-Class drug candidates—Prurisol, Kevetrin and Brilacidin—toward market approval."


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
